| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962799 | Vaccine | 2016 | 8 Pages |
Abstract
HIVAX vaccine is generally safe, elicits strong anti-HIV-1 immune responses, and may play an important role in controlling viral load during treatment interruption in HIV-1 infected participants.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Frank Y. Tung, Jack K. Tung, Suresh Pallikkuth, Savita Pahwa, Margaret A. Fischl,